ArticleMaterials today physics2023
Principles and applications of magnetic nanomaterials in magnetically guided bioimaging.
Article in Materials today physics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Biomaterials for biomarker imaging and detection.Journal of advanced research · 2026Review
- Computational design of a 3D magnetic particle imaging (MPI) prototype.AIP advances · 2026Article
- Unveiling Dipolar Interaction-Driven Magnetic Field Inhomogeneities in TAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
- Magnetic Nanoparticles: Synthesis and Applications in Life Sciences.ChemistryOpen · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Imaging plays a pivotal role in the precise diagnosis of a variety of diseases. Various imaging modalities have long secured their place in clinics. However, a lot of these techniques come with their own set of secondary complications and side effects, like ionization radiation in X-rays or positron emission tomography (PET) imaging. Unlike those, magnetically guided imaging modalities have an advantage as they do not pose any critical hazard to the body tissues while operating within acceptable thresholds. Magnetic nanoparticles (MNPs) have been thoroughly investigated as a versatile platform as contrast agents for magnetic resonance imaging (MRI) and nanotracers for magnetic particle imaging (MPI), due to their unique physical properties (i.e., super-paramagnetism) at nanoscale dimensions, and ability to function at the molecular level in biological interactions. Based on the underlying mechanism of these techniques, various parameters like shape, size, anisotropy, magnetization, and surface chemistry, become deciding factors in enhancing the performances of MNPs. Focusing on magnetically guided biomedical imaging, this review discusses the fundamental principles of MRI and MPI and their nanoscale imaging agents. This review also summarizes the existing strategies to enhance the performances and significance of MNPs, and new advances in updating current clinical diagnostics and precision nanomedicine.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.